New Delhi: The government has extended the ₹2,700-crore production-linked incentive (PLI) scheme for domestic manufacturing of medical devices till 2035-36 and invited fresh applications, easing eligibility and investment conditions to attract manufacturers and strengthen local production of high-end medical technologies.
Under the revised guidelines, the minimum sales threshold for claiming incentives has been discontinued and the minimum investment requirement reduced.
Applicants can submit multiple applications across one or more of the four target segments, while the application window will remain open for an extended period.
The online application portal is expected to become operational within the next 10 days, the Department of Pharmaceuticals said on Tuesday. Launched in 2020-21, the scheme has facilitated domestic manufacturing of more than 60 high-end medical devices and components, with production valued at over ₹16,000 crore. This includes CT scanners and dialysers.
Under the revised guidelines, the minimum sales threshold for claiming incentives has been discontinued and the minimum investment requirement reduced.
Applicants can submit multiple applications across one or more of the four target segments, while the application window will remain open for an extended period.
The online application portal is expected to become operational within the next 10 days, the Department of Pharmaceuticals said on Tuesday. Launched in 2020-21, the scheme has facilitated domestic manufacturing of more than 60 high-end medical devices and components, with production valued at over ₹16,000 crore. This includes CT scanners and dialysers.